Current Gene Therapy

Editor-in-Chief

Liang Cheng
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang
(China)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 9 Issue: 5, October

Editorial [Hot topic: Gene Therapy Continues to Make Progress: Clinical and Regulatory Perspectives (Guest Editors: Maria G. Castro and Pedro R. Lowenstein)]

Volume:9   Issue: 5
Pp: 327-328
Maria G. Castro and Pedro R. Lowenstein
DOI: 10.2174/156652309789753374
Published on: 01 March, 2012

Progress Towards Liver and Lung-Directed Gene Therapy with Helper- Dependent Adenoviral Vectors

Volume:9   Issue: 5
Pp: 329-340
Nicola Brunetti-Pierri and Philip Ng
DOI: 10.2174/156652309789753310
Published on: 01 March, 2012

“Buy One Get One Free”: Armed Viruses for the Treatment of Cancer Cells and their Microenvironment

Volume:9   Issue: 5
Pp: 341-355
Balveen Kaur, Timothy P. Cripe and E. Antonio Chiocca
DOI: 10.2174/156652309789753329
Published on: 01 March, 2012

Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma

Volume:9   Issue: 5
Pp: 356-367
Ann-Marie Maatta, Haritha Samaranayake, Jere Pikkarainen, Thomas Wirth and Seppo Yla-Herttuala
DOI: 10.2174/156652309789753365
Published on: 01 March, 2012

Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?

Volume:9   Issue: 5
Pp: 368-374
Pedro R. Lowenstein and Maria G. Castro
DOI: 10.2174/156652309789753392
Published on: 01 March, 2012

Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinsons Disease

Volume:9   Issue: 5
Pp: 375-388
Fredric p. Manfredsson, Michael S. Okun and Ronald J. Mandel
DOI: 10.2174/156652309789753400
Published on: 01 March, 2012

Stem Cells as Delivery Vehicles for Oncolytic Adenoviral Virotherapy

Volume:9   Issue: 5
Pp: 389-395
Justin Kranzler, Matthew A. Tyler, Adam M. Sonabend, Ilya V. Ulasov and Maciej S. Lesniak
DOI: 10.2174/156652309789753347
Published on: 01 March, 2012

Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes

Volume:9   Issue: 5
Pp: 396-408
Juan F. Vera, Malcolm K. Brenner and Gianpietro Dotti
DOI: 10.2174/156652309789753338
Published on: 01 March, 2012

Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety

Volume:9   Issue: 5
Pp: 409-421
Marianela Candolfi, Kurt M. Kroeger, A. K.M.G. Muhammad, Kader Yagiz, Catherine Farrokhi, Robert N. Pechnick, Pedro R. Lowenstein and Maria G. Castro
DOI: 10.2174/156652309789753301
Published on: 01 March, 2012

Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas

Volume:9   Issue: 5
Pp: 422-427
Hong Jiang, Candelaria Gomez-Manzano, Frederick F. Lang, Ramon Alemany and Juan Fueyo
DOI: 10.2174/156652309789753356
Published on: 01 March, 2012

AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS

Volume:9   Issue: 5
Pp: 428-433
Mark E. Hester, Kevin D. Foust, Rita W. Kaspar and Brian K. Kaspar
DOI: 10.2174/156652309789753383
Published on: 01 March, 2012